ArticleChinese medical journal2026

Efficacy and toxicity of maintenance therapy with PD-1/PD-L1 inhibitors plus pemetrexed vs . immunotherapy alone for stage III/IV non-squamous non-small cell lung cancer: A real-world study.

Zijian Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.